Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Innocenti

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Cardiovascular Medicine|November 29, 2023
Editorial: Cardiovascular involvement during sepsis: therapeutic and prognostic consequencesF Innocenti, V Palmieri
Clinical Pharmacology and Therapeutics|November 18, 2014
Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continuesN K Gillis, F Innocenti
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J Ratain
European Journal of Dermatology : EJD|July 3, 1998
Guess what! Scrofuloderma (tuberculosis colliquativa cutis) of the left footR Cecchi, A Giomi, F Innocenti
Journal of Pharmaceutical Sciences|May 1, 1980
Thermal decomposition of ibuproxamS Chimichi, F Innocenti, G Orzalesi
Clinical Pharmacokinetics|December 7, 2000
Pharmacogenetics: a tool for individualizing antineoplastic therapyF Innocenti, L Iyer, M J Ratain
Annual Review of Medicine|January 15, 2003
Pharmacogenetics in cancer treatmentR Nagasubramanian, F Innocenti, M J Ratain
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecanF Innocenti, L Iyer, M J Ratain
Critical Reviews in Oncology/Hematology|June 13, 2018
"No pain, No gain" still true with immunotherapy: When the finger shows the moon, look at the moon!G Milano, F Innocenti, B Lacarelle, et al.
Clinical Pharmacology and Therapeutics|October 19, 2013
Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing eraN K Gillis, J N Patel, F Innocenti
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Cardiovascular Medicine|November 29, 2023
Editorial: Cardiovascular involvement during sepsis: therapeutic and prognostic consequencesF Innocenti, V Palmieri
Clinical Pharmacology and Therapeutics|November 18, 2014
Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continuesN K Gillis, F Innocenti
European Journal of Cancer (Oxford, England : 1990)|March 28, 2002
Update on pharmacogenetics in cancer chemotherapyF Innocenti, M J Ratain
European Journal of Dermatology : EJD|July 3, 1998
Guess what! Scrofuloderma (tuberculosis colliquativa cutis) of the left footR Cecchi, A Giomi, F Innocenti
Journal of Pharmaceutical Sciences|May 1, 1980
Thermal decomposition of ibuproxamS Chimichi, F Innocenti, G Orzalesi
Clinical Pharmacokinetics|December 7, 2000
Pharmacogenetics: a tool for individualizing antineoplastic therapyF Innocenti, L Iyer, M J Ratain
Annual Review of Medicine|January 15, 2003
Pharmacogenetics in cancer treatmentR Nagasubramanian, F Innocenti, M J Ratain
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 22, 2001
Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecanF Innocenti, L Iyer, M J Ratain
Critical Reviews in Oncology/Hematology|June 13, 2018
"No pain, No gain" still true with immunotherapy: When the finger shows the moon, look at the moon!G Milano, F Innocenti, B Lacarelle, et al.
Clinical Pharmacology and Therapeutics|October 19, 2013
Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing eraN K Gillis, J N Patel, F Innocenti
Pageof 10